Key result
Uridine triacetate reverses fulminant 5-fluorouracil-induced cardiogenic shock following drug cessation.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case highlights that 5-fluorouracil cardiotoxicity can present as fulminant but reversible left ventricular dysfunction and cardiogenic shock.
5‐Fluorouracil (5‐FU), a chemotherapeutic agent, is routinely used for solid tumors. Known cardiotoxic effects of 5‐FU include fatal arrhythmias, myocardial infarctions, and coronary vasospasms. This case report describes a 56‐year‐old man who had acute heart failure with cardiogenic shock suspected to be related to 5‐FU exposure; notably, cardiac dysfunction resolved following cessation of therapy.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2026) conducted a case report in 5-Fluorouracil-associated cardiotoxicity (n=1). 5-Fluorouracil was evaluated on Development and resolution of acute heart failure with cardiogenic shock. A 56-year-old man developed fulminant but reversible acute heart failure and cardiogenic shock during 5-fluorouracil infusion, which resolved after drug cessation and uridine triacetate administration.
Synapse has enriched 10 related papers. Consider them for comparative context: